References
- 1. International Agency for Research on Cancer (IARC): Tobacco Smoke and Involuntary Smoking; IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans, Vol. 83, IARC, Lyon, France, 2004.
- 2. US Department of Health and Human Service: The Health Consequences of Smoking: A Report of the Surgeon General; (2004) Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Washington DC, USA; available at: http://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm (Accessed September 2014).
- 3. Thun, M.J.: Tobacco Use and Cancer: An Epidemiologic Perspective; in: Alcohol, Tobacco and Cancer; edited by C.H. Cho and V. Purohit, Karger AG, Basel, Switzerland, 2006, pp. 189-204.
- 4. Halle, W. and H. Spielmann: Two Procedures for the Prediction of Acute Toxicity (LD50) From Cytotoxicity Data; ATLA 20 (1992) 40-49.
- 5. Shrivastava, R., C. Delomenie, A. Chevalier, G. John, B. Ekwall, E. Walum, and R. Massingham: Comparison of In Vivo Acute Lethal Potency and In Vitro Cytotoxicity of 48 Chemicals; Cell Biol. Toxicol. 8 (1992) 157-170.
- 6. Ekwall, B.: Overview of the Final MEIC Results: II. The In Vitro -- In Vivo Evaluation, Including the Selection of A Practical Battery of Cell Tests for Prediction of Acute Lethal Blood Concentrations in Humans; Toxicol. In Vitro 13 (1999) 665-673.
- 7. National Institute of Environmental Health Sciences: Guidance Document on Using In Vitro Data to Estimate In Vitro Starting Doses for Acute Toxicity; NIH Publication No. 01-4500 (2001) National Toxicology Program, National Institutes of Health, US Public Health Service and US Department of Health and Human Services NC, USA; available at: http://www.epa.gov/hpv/pubs/general/nih2001b.pdf. (Assessed September 2014).
- 8. Klimisch, H.J. and W. Dontenwill: Investigations of Cigarette Smoke Dosages in Inhalation Experiments with Syrian Hamsters. I. Concentration of Cigarette Smoke in the Inhalation Chamber and of Carbon Monoxide in the Blood; J Nat. Cancer Inst. 58 (1977) 931-933.
- 9. Bombick, D.W., K. Putnam, and D.J. Doolittle: Comparative Cytotoxicity Studies of Smoke Condensates From Different Types of Cigarettes and Tobaccos; Toxicol. In Vitro 12 (1998) 241-249.
- 10. Andreoli, C., D. Gigante, and A. Nunziata: A Review of In Vitro Methods to Assess the Biological Activity of Tobacco Smoke with the Aim of Reducing the Toxicity of Smoke; Toxicol. In Vitro 17 (2003) 587-594.
- 11. Life Science Research Office (LSRO): Biological Effects Assessment in the Evaluation of Potential Reduced-Risk Tobacco Products; edited by A.M. Brownawell, LSRO, Bethesda, Maryland, USA, 2007.
- 12. Rodgman, A. and T.A. Perfetti: The Chemical Components of Tobacco and Tobacco Smoke, 2nd Edition; CRC press, Boca Raton, Florida, USA, 2013.
- 13. Perfetti, T.A. and A. Rodgman: The Complexity of Tobacco and Tobacco Smoke; Beitr. Tabakforsch. Int. 24 (2011) 215-232.
- 14. DeMarini, D.M.: Genotoxicity of Tobacco Smoke and Tobacco Smoke Condensate: A Review; Mutat. Res. 567 (2004) 447-474.
- 15. Johnson, M.D., J. Schilz, M.V. Djordjevic, J.R. Rice, and P.G. Shields: Evaluation of In Vitro Assays for Assessing the Toxicity of Cigarette Smoke and Smokeless Tobacco; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3263-3304.
- 16. Adamson, J., L.E. Haswell, G. Phillips, and M.D. Gaça: In Vitro Models of Chronic Obstructive Pulmonary Disease (COPD); in: Bronchitis, edited by I. Martin-Loeches, InTech, Rijeka, Croatia, 2011.
- 17. Fearon I.M., M.D. Gaça, and B.K. Nordskog: In Vitro Models for Assessing the Potential Cardiovascular Disease Risk Associated with Cigarette Smoking; Toxicol. In Vitro 27 (2013) 513-522.
- 18.Bombick, B.R., H. Murli, J.T. Avalos, D.W. Bombick, W.T. Morgan, K.P. Putnam, and D.J. Doolittle: Chemical and Biological Studies of A New Cigarette That Primarily Heats Tobacco. Part 2. In Vitro Toxicology of Mainstream Smoke Condensate; Food Chem. Toxicol. 36 (1998) 183-90.
- 19. DeMarini, D.M., R. Gudi, A. Szkudlinska, M. Rao, L. Recio, M. Kehl, P.E. Kirby, G. Polzin, and P.A. Richter: Genotoxicity of 10 Cigarette Smoke Condensates in Four Test Systems: Comparisons Between Assays and Condensates; Mutat. Res. 650 (2008) 15-29.
- 20. Gaworski, C.L., H. Schramke, J. Diekmann, T.J. Meisgen, F.J. Tewes, D.J. Veltel, P.M. Vanscheeuwijck, N. Rajendran, M. Muzzio, and H.J. Haussmann: Effect of Filtration by Activated Charcoal on the Toxicological Activity of Cigarette Mainstream Smoke From Experimental Cigarettes; Inhal. Toxicol. 21 (2009) 688-704.
- 21.Combes, R., K. Scott, D. Dillon, C. Meredith, K. McAdam, and C. Proctor: The Effect of A Novel Tobacco Process on the In Vitro Cytotoxicity and Genotoxicity of Cigarette Smoke Particulate Matter; Toxicol. In vitro 26 (2012) 1022-1029.
- 22. CORESTA In Vitro Toxicology Task Force: The Rationale and Strategy for Conducting In Vitro Toxicology Testing of Tobacco Smoke; CORESTA Reports, Paris, France, 2014; available at: http://www.coresta.org/Reports/IVT_TF_Rationale-IVT-TestingTob.-Smoke_Report_Jun04.pdf (Assessed September 2014) .
- 23. Ishiyama, M., H. Tominaga, M. Shiga, K. Sasamoto, Y. Ohkura, and K. Ueno: A Combined Assay of Cell Viability and In Vitro Cytotoxicity with a Highly Water-Soluble Tetrazolium Salt, Neutral Red and Crystal Violet; Biol. Pharm. Bull. 19 (1996) 1518-1520.
- 24. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH): Guidance on Genotoxicity and Data Interpretation for Pharmaceuticals Intended for Human Use S2(R1); ICH Harmonised Tripartite Guideline, 2011; available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step4/S2R1_Step4.pdf (Assessed September 2014).
- 25. Borenfreund, E. and J.A. Puerner: A Simple Quantitative Procedure Using Monolayer Cultures for Cytotoxicity Assays (HTD/NR-90); J. Tissue Cult. Methods 9 (1985), 7-9.
- 26. Ishiyama, M., M. Shiga, K. Sasamoto, M. Mizoguchi, and P.G. He: A New Sulfonated Tetrazolium Salt That Produces A Highly Water-soluble Formazan Dye; Chem. Pharm. Bull. 41 (1993) 1118-1122.
- 27. International Organization for Standardization (ISO) ISO 3402. Tobacco and Tobacco Products - Atmosphere for Conditioning and Testing; ISO, Geneva, Switzerland, 1999.
- 28. International Organization for Standardization (ISO): ISO 3308. Routine Analytical Cigarette Smoking Machine - Definitions and Standard Conditions. ISO, Geneva, Switzerland, 2000.
- 29. Health Canada: Health Canada Tobacco Reporting Regulations; Health Canada, Ontario, Canada, 2005 available at: http://www.hc-sc.gc.ca/hc-ps/tobactabac/legislation/reg/indust/method/index-eng.php #main (Assessed September 2014).
- 30. Food and Drug Administration: Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke - Established List; Federal Register Vol. 77, Docket No. FDA-2012-N-0143, FDA, Maryland, USA, 2012, pp. 20034-37.
- 31. Slater, T.F., B. Sawyer, and U. Straeuli: Studies on Succinate-Tetrazolium Reductase Systems. III. Points of Coupling of Four Different Tetrazolium Salts; Biochim. Biophys. Acta. 77 (1963) 383-393.
- 32. Berridge, M.V. and A.S. Tan: Characterization of the Cellular Reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular Localization, Substrate Dependence, and Involvement of Mitochondrial Electron Transport in MTT Reduction; Arch. Biochem. Biophys. 303 (1993) 474-482.
- 33. Arechabala, B., C. Coiffard, P. Rivalland, L.J. Coiffard, and Y. de Roeck-Holtzhauer: Comparison of Cytotoxicity of Various Surfactants Tested on Normal Human Fibroblast Cultures Using the Neutral Red Test, MTT Assay and LDH Release; J. Appl. Toxicol. 19 (1999) 163-165.
- 34. Borenfreund, E., H. Babich, N. Martin-Alguacil: Comparisons of Two In Vitro Cytotoxicity Assays - The Neutral Red (NR) and Tetrazolium MTT Tests; Toxicol. In Vitro 2 (1988) 1-6.
- 35.Weyermann, J., D. Lochmann, and A. Zimmer: A Practical Note on the Use of Cytotoxicity Assays; Int. J. Pharm. 20 (2005) 369-376.
- 36. Putnam, K.P., D.W. Bombick, and D.J. Doolittle: Evaluation of Eight In Vitro Assays for Assessing the Cytotoxicity of Cigarette Smoke Condensate; Toxicol. In Vitro 16 (2002) 599-607.
- 37.Bombick, D.W. and D.J. Doolittle: The Role of Chemical Structure and Cell Type in the Cytotoxicity of Low Molecular Weight Aldehydes and Pyridines; In Vitro Toxicol. 8 (1995) 349-356.
- 38. Tewes, F.J., T.J. Meisgen, D.J. Veltel, E. Roemer, and G. Patskan; Toxicological Evaluation of An Electrically Heated Cigarette. Part 3: Genotoxicity and Cytotoxicity of Mainstream Smoke; J. Appl. Toxicol. 23 (2003) 341-348.
- 39. Aoshiba, K. and A. Nagai: Oxidative Stress, Cell Death, and Other Damage to Alveolar Epithelial Cells Induced by Cigarette Smoke; Tob. Induc. Dis. 1 (2003) 219-26.
- 40. Grafström, R.C., J.M. Dypbukt, J.C. Willey, K. Sundqvist, C. Edman, L. Atzori, and C.C. Harris: Pathobiological Effects of Acrolein in Cultured Human Bronchial Epithelial Cells; Cancer Res. 48 (1988) 1717-1721.
- 41. Chouchane, S., J.B. Wooten, F.J. Tewes, A. Wittig, B.P. Müller, D. Veltel, and J. Diekmann: Involvement of Semiquinone Radicals in the In Vitro Cytotoxicity of Cigarette Mainstream Smoke; Chem. Res. Toxicol. 19 (2006) 1602-1610.
- 42. Fotakis, G. and J.A. Timbrell: In Vitro Cytotoxicity Assays: Comparison of LDH, Neutral Red, MTT and Protein Assay in Hepatoma Cell Lines Following Exposure to Cadmium Chloride; Toxicol. Lett. 160 (2006) 171-177.